» Articles » PMID: 12150891

Blimp-1 Orchestrates Plasma Cell Differentiation by Extinguishing the Mature B Cell Gene Expression Program

Overview
Journal Immunity
Publisher Cell Press
Date 2002 Aug 2
PMID 12150891
Citations 475
Authors
Affiliations
Soon will be listed here.
Abstract

Blimp-1, a transcriptional repressor, drives the terminal differentiation of B cells to plasma cells. Using DNA microarrays, we found that introduction of Blimp-1 into B cells blocked expression of a remarkably large set of genes, while a much smaller number was induced. Blimp-1 initiated this cascade of gene expression changes by directly repressing genes encoding several transcription factors, including Spi-B and Id3, that regulate signaling by the B cell receptor. Blimp-1 also inhibited immunoglobulin class switching by blocking expression of AID, Ku70, Ku86, DNA-PKcs, and STAT6. These findings suggest that Blimp-1 promotes plasmacytic differentiation by extinguishing gene expression important for B cell receptor signaling, germinal center B cell function, and proliferation while allowing expression of important plasma cell genes such as XBP-1.

Citing Articles

BLIMP-1-dependent differentiation of T follicular helper cells into Foxp3 T regulatory type 1 cells.

Garnica J, Yamanouchi J, Clarke R, Moro J, Thiessen S, Montano J Front Immunol. 2025; 16:1519780.

PMID: 40066448 PMC: 11891242. DOI: 10.3389/fimmu.2025.1519780.


Transcription Factor Blimp-1: A Central Regulator of Oxidative Stress and Metabolic Reprogramming in Chronic Inflammatory Diseases.

Wang A, Avina A, Liu Y, Chang Y, Kao H Antioxidants (Basel). 2025; 14(2).

PMID: 40002370 PMC: 11851694. DOI: 10.3390/antiox14020183.


Resveratrol as a BCL6 natural inhibitor suppresses germinal center derived Non-Hodgkin lymphoma cells growth.

Xing Y, Tan C, Liu Z, Liu Y, Liu S, Wang G J Nat Med. 2025; 79(2):399-411.

PMID: 39815148 PMC: 11880072. DOI: 10.1007/s11418-024-01873-4.


Characterization of class-switched B cells in chickens.

von La Roche D, Schumacher M, Kohn M, Trapp J, Schusser B, Rautenschlein S Front Immunol. 2024; 15:1484288.

PMID: 39640270 PMC: 11617357. DOI: 10.3389/fimmu.2024.1484288.


Selective Enhancer Gain-of-Function Deregulates MYC Expression in Multiple Myeloma.

Rahmat M, Clement K, Alberge J, Sklavenitis-Pistofidis R, Kodgule R, Fulco C Cancer Res. 2024; 84(24):4173-4183.

PMID: 39312195 PMC: 11649448. DOI: 10.1158/0008-5472.CAN-24-1440.